The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...

An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

Doctors warn, fatty liver can lead to liver cancer if ignored! Here's how to prevent non-alcoholic fatty liver disease.

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...

Sian Ashcroft died last year aged 35 just 18 days after she was diagnosed with cholangiocarcinoma (CCA), a form of liver ... treatments available, with more than 50% of CCA patients receiving no ...

SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.

Medivir AB (FRA:MVR0) successfully closed its Phase 1B/2A study for its liver cancer treatment, with patients transitioning to compassionate use. The company received FDA IND approval for its ...

Medivir AB (FRA:MVR0) successfully closed its Phase 1B/2A study for its liver cancer treatment, with patients transitioning to compassionate use. The company received FDA IND approval for its Phase 2B ...

Liver cancer, or hepatic cancer, is a malignant tumour that grows on the surface or inside the liver. The leading cause is a viral infection with hepatitis B or C virus. The most frequent liver ...